Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice

Hepatology

Volumn 55, Issue 6, 2012, Pages 1954-1964

  Volarevic, Vladislav ^a   Milovanovic, Marija ^a   Ljujic, Biljana ^a   Pejnovic, Nada ^a   Arsenijevic, Nebojsa ^a   Nilsson, Ulf ^b   Leffler, Hakon ^b   Lukic, Miodrag L ^a  

^a UNIVERSITY OF KRAGUJEVAC   (Serbia)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; GALECTIN 3; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4; LIVER ENZYME; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CD4 LYMPHOCYTE COUNT; CELL INFILTRATION; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITE; DOWN REGULATION; FLOW CYTOMETRY; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; LIVER INJURY; LYMPHOCYTE DIFFERENTIATION; LYMPHOID CELL; MACROPHAGE; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; SPLEEN CELL; WILD TYPE;

ANIMALS; APOPTOSIS; CONCANAVALIN A; CYTOKINES; DENDRITIC CELLS; DRUG-INDUCED LIVER INJURY; GALECTIN 3; LYMPHOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MALE; MICE; MICE, INBRED C57BL;

EID: 84861574827     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.25542     Document Type: Article

References (30)

1. Tiegs G, Hentschel J, Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 1992; 90: 196-203.
2. Mizuhara H, Uno M, Seki N, Yamashita M, Yamaoka M, Ogawa T, et al. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis. HEPATOLOGY 1996; 23: 1608-1615.
3. Volarevic V, Mitrovic M, Milovanovic M, Zelen I, Nikolic I, Mitrovic S, et al. Protective role of IL-33/ST2 axis in Con A-induced hepatitis. J Hepatol 2011; 56: 26-33.
4. Takeda K, Hayakawa Y, Van Kaer L, Matsuda H, Yagita H, Okumura K. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci U S A 2000; 97: 5498-5503.
5. Matsuda Y, Yamagiwa Y, Fukushima K, Ueno Y, Shimosegawa T. Expression of galectin-3 involved in prognosis of patients with hepatocellular carcinoma. Hepatol Res 2008; 38: 1098-1111.
6. Iacobini C, Menini S, Ricci C, Fantauzzi CB, Scipioni A, Salvi L, et al. Galectin-3 ablation protects mice from diet-induced NASH: a major scavenging role for galectin-3 in liver. J Hepatol 2011; 54: 975-983.
7. Dumic J, Dabelic S, Flogel M. Galectin-3: an open-ended story. Biochim Biophys Acta 2006; 1760: 616-635.
8. Radosavljevic G, Jovanovic I, Majstorovic I, Mitrovic M, Lisnic VJ, Arsenijevic N, et al. Deletion of galectin-3 in the host attenuates metastasis of murine melanoma by modulating tumor adhesion and NK cell activity. Clin Exp Metastasis 2011; 28: 451-462.
9. Hsu Dk, Chen HY, Liu FT. Galectin-3 regulates T-cell functions. Immunol Rev 2009; 230: 114-127.
10. Joo HG, Goedegebuure PS, Sadanaga N, Nagoshi M, von Bernstorff W, Eberlein TJ. Expression and function of galectin-3, a beta-galactoside-binding protein in activated T lymphocytes. J Leukoc Biol 2001; 69: 555-564.
11. Nieminen J, St-Pierre C, Bhaumik P, Poirier F, Sato S. Role of galectin-3 in leukocyte recruitment in a murine model of lung infection by Streptococcus pneumoniae. J Immunol. 2008; 180: 2466-2473.
12. Nachtigal M, Ghaffar A, Mayer EP. Galectin-3 gene inactivation reduces atherosclerotic lesions and adventitial inflammation in ApoE-deficient mice. Am J Pathol 2008; 172: 247-255.
13. Bernardes ES, Silva NM, Ruas LP, Mineo JR, Loyola AM, Hsu DK, et al. Toxoplasma gondii infection reveals a novel regulatory role for galectin-3 in the interface of innate and adaptive immunity. Am J Pathol 2006; 168: 1910-1920.
14. Hsu DK, Yang RY, Pan Z, Yu L, Salomon DR, Fung-Leung WP, et al. Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am J Pathol 2000; 156: 1073-1083.
15. Volarevic V, Milovanovic M, Arsenijevic N, Lukic M. The new semi-quantitative method for determination of liver damage after Concanavalin A administration. Ser J Exp Clin Res 2010; 11: 45-48.
16. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled Annexin V. J Immunol Methods 1995; 184: 39-51.
17. Liu FT, Hsu DK. The role of galectin-3 in promotion of the inflammatory response. Drug News Perspect 2007; 20: 455-460.
18. Kimura K, Sekiguchi S, Hayashi S, Hayashi Y, Hishima T, Nagaki M, et al. Role of interleukin-18 in intrahepatic inflammatory cell recruitment in acute liver injury. J Leukoc Biol 2011; 89: 433-442.
19. Jeon SB, Yoon HJ, Chang CY, Koh HS, Jeon SH, Park EJ. Galectin-3 exerts cytokine-like regulatory actions through the JAK-STAT pathway. J Immunol 2010; 185: 7037-7046.
20. Robinson R, Wang J, Cripps J, Milks M, English K, Pearson T, et al. End-organ damage in a mouse model of fulminant liver inflammation requires CD4+ T cell production of IFN-γ but is independent of Fas. J Immunol 2009; 182: 3278-3284.
21. Louis H, Le Moine O, Peny MO, Quertinmont E, Fokan D, Goldman M, et al. Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice. HEPATOLOGY 1997; 25: 1382-1389.
22. Erhardt A, Biburger M, Papadopoulos T, Tiegs G. IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice. HEPATOLOGY 2007; 45: 475-485.
23. Hsu DK, Chernyavsky AI, Chen HY, Yu L, Grando SA, Liu FT. Endogenous galectin-3 is localized in membrane lipid rafts and regulates migration of dendritic cells. J Invest Dermatol 2009; 129: 573-583.
24. Zhu R, Diem S, Araujo LM, Aumeunier A, Denizeau J, Philadelphe E, et al. The Pro-Th1 cytokine IL-12 enhances IL-4 production by invariant NKT cells: relevance for T cell-mediated hepatitis. J Immunol 2007; 178: 5435-5442.
25. Liu FT, Hsu DK, Zuberi RI, Kuwabara I, Chi EY, Henderson WR, Jr. Expression and function of galectin-3, a beta-galactoside binding lectin, in human monocytes and macrophages. Am J Pathol 1995; 147: 1016-1028.
26. Hölscher C, Atkinson RA, Arendse B, Brown N, Myburgh E, Alber G, et al. A protective and agonistic function of IL-12p40 in mycobacterial infection. J Immunol 2001; 167: 6957-6966.
27. Stout RD, Jiang C, Matta B, Tietzel I, Watkins SK, Suttles J. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol 2005; 175: 342-349.
28. MacKinnon A, Farnworth S, Hodkinson P, Henderson N, Atkinson K, Leffler H, et al. Regulation of alternative macrophage activation by galectin-3. J Immunol 2008; 180: 2650-2658.
29. Sano H, Hsu DK, Apgar JR, Yu L, Sharma BB, Kuwabara I, et al. Critical role of galectin-3 in phagocytosis by macrophages. J Clin Invest 2003; 112: 389-397.
30. Fayad R, Sennello JA, Kim SH, Pini M, Dinarello CA, Fantuzzi G. Induction of thymocyte apoptosis by systemic administration of concanavalin A in mice: role of TNF-alpha, IFN-gamma, and glucocorticoids. Eur J Immunol 2005; 35: 2304-2312.